Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zeland rabbit ocular model

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

Robert Snoeck, Takashi Sakuma, Erik De Clercq et al. · Antimicrobial Agents and Chemotherapy · 1988 · 221 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)

Robert Snoeck, Graciela Andreï, M. Gérard et al. · Clinical Infectious Diseases · 1994 · 158 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +14

Treatment With Intravenous (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)Propyl]-Cytosine Of Acyclovir-Resistant Mucocutaneous Infection With Herpes Simplexvirus In A Patient With Aids

Jacob Lalezari, William Drew, E. Glutzer et al. · The Journal of Infectious Diseases · 1994 · 96 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.

Y. J. Gordon, Eric G. Romanowski, T. Araullo-Cruz · PubMed · 1994 · 89 citations

Medicine, Infectious Diseases, Ophthalmology +15

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice

Erik De Clercq, Antonı́n Holý · Antimicrobial Agents and Chemotherapy · 1991 · 80 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15